Parvez Κhan

3.8k total citations
85 papers, 2.9k citations indexed

About

Parvez Κhan is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Parvez Κhan has authored 85 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 24 papers in Oncology and 16 papers in Organic Chemistry. Recurrent topics in Parvez Κhan's work include Cancer-related Molecular Pathways (8 papers), Enzyme function and inhibition (8 papers) and Phytochemicals and Antioxidant Activities (8 papers). Parvez Κhan is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Enzyme function and inhibition (8 papers) and Phytochemicals and Antioxidant Activities (8 papers). Parvez Κhan collaborates with scholars based in India, United States and Saudi Arabia. Parvez Κhan's co-authors include Md. Imtaiyaz Hassan, Faizan Ahmad, Asimul Islam, Aarfa Queen, Mohd W. Nasser, Mohamed F. Alajmi, Gulam Mustafa Hasan, Afzal Hussain, Anas Shamsi and Taj Mohammad and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Parvez Κhan

84 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Parvez Κhan India 33 1.6k 618 523 378 286 85 2.9k
Chunlin Zhuang China 33 2.4k 1.5× 1.7k 2.8× 519 1.0× 226 0.6× 519 1.8× 159 4.7k
Nam Doo Kim South Korea 32 1.8k 1.1× 454 0.7× 384 0.7× 230 0.6× 159 0.6× 102 2.9k
Minghai Tang China 32 1.9k 1.1× 636 1.0× 468 0.9× 115 0.3× 229 0.8× 151 3.2k
Shuxing Zhang United States 35 2.8k 1.7× 339 0.5× 631 1.2× 824 2.2× 271 0.9× 87 4.2k
Concettina La Motta Italy 36 1.5k 0.9× 1.3k 2.1× 595 1.1× 176 0.5× 387 1.4× 138 3.7k
Marinella Roberti Italy 35 1.6k 1.0× 1.5k 2.5× 459 0.9× 284 0.8× 475 1.7× 111 3.6k
Mee‐Hyun Lee South Korea 33 2.4k 1.5× 356 0.6× 739 1.4× 168 0.4× 241 0.8× 130 3.8k
Giorgio Cozza Italy 32 2.9k 1.7× 691 1.1× 559 1.1× 602 1.6× 308 1.1× 88 4.6k
John B. Bruning Australia 29 2.3k 1.4× 386 0.6× 390 0.7× 277 0.7× 252 0.9× 123 3.5k
Rajesh N. Gacche India 29 987 0.6× 867 1.4× 324 0.6× 153 0.4× 305 1.1× 105 2.7k

Countries citing papers authored by Parvez Κhan

Since Specialization
Citations

This map shows the geographic impact of Parvez Κhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parvez Κhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parvez Κhan more than expected).

Fields of papers citing papers by Parvez Κhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parvez Κhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parvez Κhan. The network helps show where Parvez Κhan may publish in the future.

Co-authorship network of co-authors of Parvez Κhan

This figure shows the co-authorship network connecting the top 25 collaborators of Parvez Κhan. A scholar is included among the top collaborators of Parvez Κhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parvez Κhan. Parvez Κhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gautam, Shailendra K., Parvez Κhan, Pranita Atri, et al.. (2023). Mucins as Potential Biomarkers for Early Detection of Cancer. Cancers. 15(6). 1640–1640. 27 indexed citations
3.
Ahmed, Sarfraz, Parvez Κhan, Anas Shamsi, et al.. (2023). Structure-Guided Design and Development of Vanillin-Triazole Conjugates as Potential MARK4 Inhibitors Targetting Hepatocellular Carcinoma. SSRN Electronic Journal. 1 indexed citations
4.
Κhan, Parvez, Asad Rehman, Shailendra Kumar Maurya, et al.. (2023). Abstract 289: B7-H3 mediated metabolic reprogramming promotes small cell lung cancer progression. Cancer Research. 83(7_Supplement). 289–289. 1 indexed citations
5.
Podany, Anthony T., Parvez Κhan, Christopher L. Shaffer, et al.. (2023). Chemotherapy in pediatric brain tumor and the challenge of the blood–brain barrier. Cancer Medicine. 12(23). 21075–21096. 7 indexed citations
6.
Yousuf, Mohd, Manzar Alam, Anas Shamsi, et al.. (2022). Structure-guided design and development of cyclin-dependent kinase 4/6 inhibitors: A review on therapeutic implications. International Journal of Biological Macromolecules. 218. 394–408. 25 indexed citations
7.
Anwar, Saleha, Parvez Κhan, Panagiotis Dalezis, et al.. (2022). Synthesis and biological activity of bisindole derivatives as novel MARK4 inhibitors. SHILAP Revista de lepidopterología. 6. 100076–100076. 11 indexed citations
8.
Maurya, Shailendra Kumar, Parvez Κhan, Asad Ur Rehman, et al.. (2021). Rethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications. Seminars in Cancer Biology. 86(Pt 3). 914–930. 14 indexed citations
9.
Anwar, Saleha, Shama Khan, Farah Anjum, et al.. (2021). Myricetin inhibits breast and lung cancer cells proliferation via inhibiting MARK4. Journal of Cellular Biochemistry. 123(2). 359–374. 41 indexed citations
10.
Κhan, Parvez, et al.. (2020). Identification of morpholine based hydroxylamine analogues: selective inhibitors of MARK4/Par-1d causing cancer cell death through apoptosis. New Journal of Chemistry. 44(38). 16626–16637. 12 indexed citations
11.
Aneja, Babita, Aarfa Queen, Parvez Κhan, et al.. (2020). Design, synthesis & biological evaluation of ferulic acid-based small molecule inhibitors against tumor-associated carbonic anhydrase IX. Bioorganic & Medicinal Chemistry. 28(9). 115424–115424. 32 indexed citations
12.
Rahman, Safikur, Md Tabish Rehman, Gulam Rabbani, et al.. (2019). Insight of the Interaction between 2,4-thiazolidinedione and Human Serum Albumin: A Spectroscopic, Thermodynamic and Molecular Docking Study. International Journal of Molecular Sciences. 20(11). 2727–2727. 62 indexed citations
13.
Saigal, Saigal, Mohammad Irfan, Parvez Κhan, Mohammad Abid, & Md. Musawwer Khan. (2019). Design, Synthesis, and Biological Evaluation of Novel Fused Spiro-4H-Pyran Derivatives as Bacterial Biofilm Disruptor. ACS Omega. 4(16). 16794–16807. 43 indexed citations
14.
Alam, Shadab, Afzal Hussain, Babita Aneja, et al.. (2019). Biofilm inhibition and DNA binding studies of isoxazole-triazole conjugates in the development of effective anti-bacterial agents. Journal of Molecular Structure. 1201. 127144–127144. 13 indexed citations
15.
Irfan, Mohammad, Parvez Κhan, Mohamed F. Alajmi, et al.. (2018). 1,2,3-Triazole–quinazolin-4(3H)-one conjugates: evolution of ergosterol inhibitor as anticandidal agent. RSC Advances. 8(69). 39611–39625. 17 indexed citations
16.
Idrees, Danish, Bhaskar Datta, Sonam Roy, et al.. (2018). Implication of sulfonylurea derivatives as prospective inhibitors of human carbonic anhydrase II. International Journal of Biological Macromolecules. 115. 961–969. 19 indexed citations
17.
Ali, Shahid, et al.. (2018). Binding mechanism of caffeic acid and simvastatin to the integrin linked kinase for therapeutic implications: a comparative docking and MD simulation studies. Journal of Biomolecular Structure and Dynamics. 37(16). 4327–4337. 56 indexed citations
18.
Naz, Farha, Faez Iqbal Khan, Taj Mohammad, et al.. (2017). Investigation of molecular mechanism of recognition between citral and MARK4: A newer therapeutic approach to attenuate cancer cell progression. International Journal of Biological Macromolecules. 107(Pt B). 2580–2589. 105 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunlin Zhuang Breakdown of academic impact, for papers by Nam Doo Kim Breakdown of academic impact, for papers by Minghai Tang Breakdown of academic impact, for papers by Shuxing Zhang Breakdown of academic impact, for papers by Concettina La Motta Breakdown of academic impact, for papers by Marinella Roberti Breakdown of academic impact, for papers by Mee‐Hyun Lee Breakdown of academic impact, for papers by Giorgio Cozza Breakdown of academic impact, for papers by John B. Bruning Breakdown of academic impact, for papers by Rajesh N. Gacche
Rankless by CCL
2026